CN111351892A - Radix ophiopogonis detection method - Google Patents

Radix ophiopogonis detection method Download PDF

Info

Publication number
CN111351892A
CN111351892A CN201811570788.4A CN201811570788A CN111351892A CN 111351892 A CN111351892 A CN 111351892A CN 201811570788 A CN201811570788 A CN 201811570788A CN 111351892 A CN111351892 A CN 111351892A
Authority
CN
China
Prior art keywords
solution
water
methanol
radix ophiopogonis
medicinal material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811570788.4A
Other languages
Chinese (zh)
Inventor
孙秋亚
江廷峰
李东慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei Wanbang Folon Pharmaceutical Co ltd
Original Assignee
Hebei Wanbang Folon Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei Wanbang Folon Pharmaceutical Co ltd filed Critical Hebei Wanbang Folon Pharmaceutical Co ltd
Priority to CN201811570788.4A priority Critical patent/CN111351892A/en
Publication of CN111351892A publication Critical patent/CN111351892A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90Plate chromatography, e.g. thin layer or paper chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90Plate chromatography, e.g. thin layer or paper chromatography
    • G01N30/94Development

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

The invention relates to the technical field of traditional Chinese medicines, and particularly relates to a detection method of radix ophiopogonis. The ruscogenin is detected by adopting a thin-layer chromatography identification method, so that the technical problem of the radix ophiopogonis identification method is solved. The method has strong durability, and can monitor the quality of the radix ophiopogonis products more effectively.

Description

Radix ophiopogonis detection method
Technical Field
The invention relates to the technical field of traditional Chinese medicines. In particular to a detection method for identifying the traditional Chinese medicine radix ophiopogonis by adopting thin-layer chromatography.
Background
Ophiopogon japonicus is recorded in the section of 'Chinese pharmacopoeia' 2015 edition, only a reference medicinal material is used as a reference under the identification item of the Ophiopogon japonicus in the original quality standard, and silica gel GF is adopted254When the plate is unfolded for detection and observed under an ultraviolet lamp at 254nm, the spots are occasionally unclear and are difficult to compare and judge. The ruscogenin reference substance is added in the method as a reference, the silica gel G plate is adopted for unfolding, the spots are clear and identifiable, the quality of the medicinal materials can be better controlled, and the method removes the use of trichloromethane, so that the method is more environment-friendly.
Disclosure of Invention
The invention aims to solve the technical problem of designing a method for identifying and detecting the radix ophiopogonis medicinal material, so that the product quality is effectively controlled.
The invention provides a detection method for identifying a radix ophiopogonis medicinal material.
Drawings
The effect of the invention can be illustrated by fig. 1-5, and the detection method is stable and reliable.
FIG. 1 is a thin layer chromatogram for identification of Ophiopogon japonicus;
FIG. 2 is a graph of a homemade layout in a durability test;
FIG. 3 is a graph of a typical commercial plate in a durability test;
FIG. 4 is a graph of a durability test at 10-20 ℃;
FIG. 5 is a 25-30 ℃ chart in a durability test.
Detailed Description
The invention can be realized by the following scheme:
1. instrument, reagent and test sample information
(1) Instrument for measuring the position of a moving object
An electronic balance: model HK-JC-220AB
A water bath kettle: type HH-6
A drying oven: model 202-2
(2) Reagent and reagent
Methanol, hydrochloric acid, toluene, glacial acetic acid, and 10% sulfuric acid ethanol solution.
(3) Reference medicinal material
Radix ophiopogonis: the batches 121013, 201310, 181122-02, 121013, 201310, 181122-03,
121013-.
Ruscogenin: lot No. 111909-201204-160215-04, China food and drug inspection research institute.
(4) Test sample
Radix ophiopogonis: the lot numbers 2017-.
(5) Method of producing a composite material
Sample amount of spotting: 3-5 mu l
Thin-layer plate: silica gel G thin layer plate
Developing solvent toluene-methanol-glacial acetic acid (80: 5: 0.25)
Color developing agent: 10% sulfuric acid ethanol solution
Color development conditions are as follows: baking at 110 ℃ for 5-7 minutes
2. Sample assay
① preparation of control solution
Taking 3g of radix Ophiopogonis as reference material, adding 50ml of methanol, heating and refluxing for 2h, standing, taking supernatant, evaporating to dryness, adding 40ml of water into residue for dissolving, adding 1ml of hydrochloric acid, slightly boiling, heating and refluxing for 1h, cooling, transferring into a separating funnel, extracting with water saturated n-butanol for 3 times, 40ml each time, combining extractive solutions, washing with water for 2 times, 50ml each time, discarding water washing solution, recovering n-butanol to dryness, adding 2ml of methanol into residue for dissolving, and taking the residue as reference material solution.
② preparation of control solutions
Precisely weighing ruscogenin 5mg, adding methanol 5ml to obtain 1mg solution per 1ml, and making into reference solution.
③ preparation of test solution
Taking 3g of radix ophiopogonis, adding 50ml of methanol, heating and refluxing for 2h, standing, taking supernatant, evaporating to dryness, adding 40ml of water into residue for dissolving, adding 1ml of hydrochloric acid, slightly boiling, heating and refluxing for 1h, cooling, transferring into a separating funnel, extracting with water-saturated n-butanol for 3 times, 40ml each time, combining extracting solutions, washing with water for 2 times, 50ml each time, discarding water washing solution, recovering n-butanol to dryness, adding 2ml of methanol into residue for dissolving, and taking the residue as a control solution.
④ method of measurement
Performing a thin-layer chromatography test according to general rule 0502, sucking 3-5 mu l of each of a control medicinal material solution, a control solution and a sample solution, respectively dropping the control medicinal material solution, the control solution and the sample solution on the same silica gel G thin-layer plate, presaturating the silica gel G thin-layer plate for 10-15 min by using toluene-methanol-glacial acetic acid (80: 5: 0.25) as a developing agent, developing, taking out, drying, spraying a 10% sulfuric acid ethanol solution, and drying the silica gel G thin-layer plate for 5-7 min at 110 ℃ until spots are clearly developed.
⑤ test standards
Spots of the same color appear on the chromatogram of the test solution at the positions corresponding to the chromatograms of the reference solution and the reference medicinal material.
⑥ test results
The dwarf lilyturf tuber medicinal materials (the batch numbers are 2017-217, 2018-440 and 2018-167) show spots with the same color on the positions corresponding to the color spectrum of the reference substance and the color spectrum of the reference substance. The chromatographic results are shown in FIG. 1.
3. Durability test
(1) Influence of different brands of silica gel G thin layer plates on test
① silica gel G thin layer plates of different brands, including commercially available silica gel G thin layer plate and self-made silica gel G thin layer plate
Commercially available silica gel G thin layer plates: activation was carried out for 30 minutes at 110 ℃ just before use.
The preparation method of the self-made silica gel G thin-layer plate comprises the following steps: grinding and mixing 1 part of stationary phase (silica gel G) and 3 parts of adhesive (0.25% sodium carboxymethylcellulose aqueous solution) in the same direction in a mortar, removing bubbles on the surface, pouring into a coater, smoothly moving the coater on a glass plate for coating (the thickness is 0.2-0.3 mm), taking down the coated thin-layer glass plate, placing the glass plate on a horizontal table, airing at room temperature, and drying at 110 ℃ for 30 minutes, namely, in a drying box with a drying agent for later use.
② test method
And (3) respectively dropping the prepared reference substance, the reference medicinal material solution and three batches of sample solutions on the same common commercially available silica gel G plate and a self-made silica gel G plate, presaturating for 10-15 min by taking toluene-methanol-glacial acetic acid (80: 5: 0.25) as a developing agent, developing, taking out, drying in the air, spraying with 10% sulfuric acid ethanol solution, and drying at 110 ℃ for 5-7 min until spots are clearly developed.
③ test standards
The spots of the sample, the reference substance and the reference medicinal material should be clearly distinguished, and the spots with the same color should be displayed on the corresponding positions of the chromatogram of the sample and the chromatogram of the reference medicinal material.
④ test results
The spots of the sample, the reference substance and the reference medicinal material should be clearly distinguished, and the spots with the same color should be displayed on the corresponding positions of the chromatogram of the sample and the chromatogram of the reference medicinal material. The results of the self-made plate spectrum are shown in figure 2, and the results of the common commercial plate are shown in figure 3.
(2) Effect of different temperatures on the test
① test method
Respectively dropping the prepared reference substance, reference medicinal material solution and three batches of sample solutions on the same silica gel G thin-layer plate, simultaneously preparing 2 thin-layer plates, and respectively developing at 10-20 deg.C and 25-30 deg.C with toluene-methanol-glacial acetic acid (80: 5: 0.25) as developing agent.
② test standards
At the temperature of 10-20 ℃ and 25-30 ℃, spots of the test sample, the reference sample and the reference drug are clear and distinguishable, and spots with the same color are displayed on the corresponding positions of the chromatogram of the test sample and the chromatogram of the reference drug.
The spectra of the 2 thin-layer plates should be consistent.
③ test results
At the temperature of 10-20 ℃ and 25-30 ℃, spots of the test sample, the reference sample and the reference drug are clear and distinguishable, and spots with the same color are displayed on the corresponding positions of the chromatogram of the test sample and the chromatogram of the reference drug.
The spectra of the 2 thin-layer plates are consistent. The graph results at 10-20 ℃ are shown in figure 4, and the graph results at 25-30 ℃ are shown in figure 5.

Claims (1)

1. The detection method of radix ophiopogonis is characterized by comprising the following steps of:
preparing a contrast medicinal solution, namely taking 3g of radix ophiopogonis contrast medicinal material, adding 50ml of methanol, heating and refluxing for 2h, standing, taking supernatant to be dried by distillation, adding 40ml of water into residues for dissolving, adding 1ml of hydrochloric acid, slightly boiling, heating and refluxing for 1h, cooling, transferring into a separating funnel, extracting for 3 times with water-saturated n-butanol, 40ml each time, combining extracting solutions, washing for 2 times with water, 50ml each time, discarding a water washing solution, recovering the n-butanol to be dry, and adding 2ml of methanol into residues for dissolving to serve as the contrast medicinal solution;
preparation of control solution A solution containing ruscogenin 5mg, methanol 5ml, and 1mg per 1ml is prepared by weighing ruscogenin 5mg, and making into control solution;
preparing a test solution by taking 3g of radix ophiopogonis medicinal material, adding 50ml of methanol, heating and refluxing for 2h, standing, taking supernatant to be dried by distillation, adding 40ml of water into residue to dissolve, adding 1ml of hydrochloric acid, slightly boiling, heating and refluxing for 1h, cooling, transferring into a separating funnel, extracting with water-saturated n-butanol for 3 times, 40ml each time, combining extracting solutions, washing with water for 2 times, 50ml each time, discarding a water washing solution, recovering the n-butanol to be dry, adding 2ml of methanol into residue to dissolve, and taking the residue as a control medicinal material solution;
the determination method is tested according to thin-layer chromatography of general 0502 in Chinese pharmacopoeia, 3-5 mul of a control medicinal material solution, a control solution and a test solution are respectively sucked and respectively spotted on the same silica gel G thin-layer plate, toluene-methanol-glacial acetic acid (80: 5: 0.25) is used as a developing agent, pre-saturation is carried out for 10-15 min, the solution is developed, taken out, dried in the air, sprayed with 10% sulfuric acid ethanol solution, and dried at 110 ℃ for 5-7 min until spots are clearly developed.
CN201811570788.4A 2018-12-21 2018-12-21 Radix ophiopogonis detection method Pending CN111351892A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811570788.4A CN111351892A (en) 2018-12-21 2018-12-21 Radix ophiopogonis detection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811570788.4A CN111351892A (en) 2018-12-21 2018-12-21 Radix ophiopogonis detection method

Publications (1)

Publication Number Publication Date
CN111351892A true CN111351892A (en) 2020-06-30

Family

ID=71191871

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811570788.4A Pending CN111351892A (en) 2018-12-21 2018-12-21 Radix ophiopogonis detection method

Country Status (1)

Country Link
CN (1) CN111351892A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1911395A (en) * 2005-08-12 2007-02-14 北京联合西创药物科技有限公司 Method for controlling quality of injection contg. traditional Chinese medicine
CN1954868A (en) * 2005-10-27 2007-05-02 北京奇源益德药物研究所 Yinju Qingyan Preparation for treating disease by flaring-up of fire of deficiency type and preparation method and quality control method
CN101036748A (en) * 2007-04-18 2007-09-19 贵州信邦制药股份有限公司 Quality control method of the Yixinshu Chinese traditional medicine for supplementing qi and for promoting blood circulation by removing blood stasis
CN101596273A (en) * 2009-06-30 2009-12-09 贵州信邦制药股份有限公司 The method of quality control of Radix Ophiopogonis in the YIXINSHU Chinese medicine preparation
CN102068626A (en) * 2009-11-19 2011-05-25 天津中新药业集团股份有限公司乐仁堂制药厂 Quality control method for infantile cough syrup as Chinese medicine preparation
CN107621517A (en) * 2016-07-14 2018-01-23 天津同仁堂集团股份有限公司 A kind of detection method of Kechuanjing Syrup

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1911395A (en) * 2005-08-12 2007-02-14 北京联合西创药物科技有限公司 Method for controlling quality of injection contg. traditional Chinese medicine
CN1954868A (en) * 2005-10-27 2007-05-02 北京奇源益德药物研究所 Yinju Qingyan Preparation for treating disease by flaring-up of fire of deficiency type and preparation method and quality control method
CN101036748A (en) * 2007-04-18 2007-09-19 贵州信邦制药股份有限公司 Quality control method of the Yixinshu Chinese traditional medicine for supplementing qi and for promoting blood circulation by removing blood stasis
CN101596273A (en) * 2009-06-30 2009-12-09 贵州信邦制药股份有限公司 The method of quality control of Radix Ophiopogonis in the YIXINSHU Chinese medicine preparation
CN102068626A (en) * 2009-11-19 2011-05-25 天津中新药业集团股份有限公司乐仁堂制药厂 Quality control method for infantile cough syrup as Chinese medicine preparation
CN107621517A (en) * 2016-07-14 2018-01-23 天津同仁堂集团股份有限公司 A kind of detection method of Kechuanjing Syrup

Similar Documents

Publication Publication Date Title
CN108645942A (en) The high performance liquid chromatography tandem mass spectrum detection method of 25-hydroxy-vitamin D in serum
CN110146600B (en) Preparation method and detection method of fructus psoraleae standard decoction
CN111351892A (en) Radix ophiopogonis detection method
CN102139039B (en) Quality control method of coptis tablet for clearing away stomach heat
CN104849369B (en) The attached sweet drug quality detection method of a kind of fiber crops
CN104502485B (en) The quantitative analysis method of 6 chemical compositions in the compound Chinese medicinal preparation that is medicinal material by rhizoma dioscoreae nipponicae and wilsonii
CN113759065B (en) Method for simultaneously identifying components of coptis chinensis and phellodendron amurense and application of method
CN102139067A (en) Quality control method for antipyretic and antitoxic tablet
CN113495110A (en) Method for simultaneously measuring 4 effective components in dandelion bluish green blue particles
CN101008634A (en) Method for identifying hawthorn of hawthorn extract lipid-lowering dispersion tablet
CN102139040A (en) Quality control method of tablet capable of clearing lung and inhibiting fire
CN104833754B (en) A kind of attached sweet drug detection method
CN101987154B (en) Thin-layer chromatographic detection method for cornel in gynecological recovery pills
CN101559169A (en) Quality control method of jianyanling capsule
CN113607871B (en) Thin layer detection method for rapidly identifying various organic acid salts
CN108802260B (en) Thin-layer identification method for quality control of lotus leaf medicinal materials, decoction pieces and formula granules
CN105738557A (en) Thin-layer chromatography detection method for icmomordin Ic in Fuyang granules
CN108776182A (en) One kind is for food and the how remaining detection method of hormone in health food
CN110857938B (en) Method for simultaneously identifying lucid ganoderma and vine of multiflower knotweed in traditional Chinese medicine composition
CN114965751A (en) Method for measuring chemical component content in myrobalan
CN110018269B (en) Thin-layer identification method for salt flatstem milkvetch seed formula granules
CN112526057A (en) Thin-layer chromatography identification method of Fuyanjing capsule
CN110857939A (en) Detection method of traditional Chinese medicine composition with sleep improvement function
CN101762640A (en) Detection method of traditional Chinese medicine for clearing heat
CN104991032A (en) Thin layer chromatography for identifying doped kadsura longepedunculata in Chinese magnoliavine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200630

WD01 Invention patent application deemed withdrawn after publication